Spores of Mucor ramosissimus, Mucor plumbeus and Mucor circinelloides and their ability to activate human complement system in vitro

References

• Speth C, Rambach G, Würzner R, Lass-Flörl C. Complement and fungal pathogens: an update. Mycoses 2008; 51:477–496.
   PubMedGoogle Scholar
• Runza VL, Schwaeble W, Männel DN. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008; 213:297–306.
   PubMedGoogle Scholar
• Abdel-Hafez SII. Composition of fungal flora of four cereal grains in Saudi Arabia. Mycopathologia 1984; 85:53–57.
   PubMedGoogle Scholar
• Alonso A, Rodriguez SR, Rodriguez SM, . Intersticial pneumonites induced in guinea pigs by the antigens of Rhizopus nigricans. J Investig Allergol Clin Immunol 1997; 7:103–109.
   PubMed Web of Science ®Google Scholar
• Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25:215–229.
   PubMed Web of Science ®Google Scholar
• Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; S1:31–47.
   Google Scholar
• Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002; 16:895–914.
   PubMed Web of Science ®Google Scholar
• Chan-Tack KM, Nemoy LL, Perencevich EN. Central venous catheter-associated fungemia secondary to mucormycosis. Scand J Infect Dis 2005; 37:925–927.
   PubMed Web of Science ®Google Scholar
• Chandra S, Woodgyer A. Primary cutaneous zygomycosis due to Mucor circinelloides. Australas J Dermatol 2002; 43:39–42.
   PubMedGoogle Scholar
• Iwen PC, Sigler L, Noel RK, Freifeld AG. Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol 2007; 45:636–640.
   PubMedGoogle Scholar
• Bullock JD, Jampol LM, Fezza AJ. Two cases of orbital phycomycosis with recovery. Am J Ophthalmol 1974; 78:811–815.
   PubMed Web of Science ®Google Scholar
• Vignale R, Mackinnon JE, Casella De Vilaboa E, Burgoa F. Chronic, destructive, mucocutaneous phycomycosis in man. Sabouraudia 1964; 3:143–147.
   PubMedGoogle Scholar
• Weitzman I, Della-Latta P, Housey G, Rebatta G. Mucor ramosissimus Samutsevitsch isolated from a thigh lesion. J Clin Microbiol 1993; 31:2523–2525.
   PubMedGoogle Scholar
• Areche C, Loyola LA, Borquez J, Rovirosa J, San-Martin A. Microbial transformation of the diterpene mulin-11,13-dien-20-oic acid by Mucor plumbeus. Magn Reson Chem 2008; 46:765–768.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tan TK, Tan GK, Connolly JD, Harrison LJ. Microbial transformation of the sesquiterpenoid (-)-maalioxide by Mucor plumbeus. Phytochem 2006; 67:58–61.
   PubMedGoogle Scholar
• Marx RS, Forsyth KR, Hentz SK. Mucorales species activation of a serum leukotactic factor. Infect Immun 1982; 38:1217–1222.
   PubMedGoogle Scholar
• Lima AO, Silva WD. Imunologia, Imunopatologia, Alergia-Métodos, 1st. Rio de Janeiro: Guanabara Koogan, 1970.
   Google Scholar
• Mayer MM. Chapter 4: Complement and complement fixation. Kabat EA, Mayer MM. Experimental Immunochemistry, 2nd. Springfield: Thomas Publisher, 1961; 133–240.
   Google Scholar
• Voller A, Bidwell DE. Enzyme-linked immunosorbent assay. Rose NR, Friedman H, Faley J. Manual of Clinical Laboratory Immunology, 3rd. Washington, DC: American Society for Microbiology1986.
   Google Scholar
• Fine DP. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun 1975; 12:772–778.
   PubMed Web of Science ®Google Scholar
• Bouza E, Muñoz P, Guinea J. Mucormycosis: an emerging disease? Clin Microbiol Infect 2006; 12:7–23.
   Google Scholar
• Kozel TR. Complement activation by pathogenic fungi. Res Immunol 1998; 149:309–320.
   PubMedGoogle Scholar
• Pinto MR, Melillo D, Giacomelli S, Sfyroera G, Lambris JD. Ancient origin of the complement system: emerging invertebrate models. Adv Exp Med Biol 2007; 598:372–388.
   PubMedGoogle Scholar
• Zhu Y, Thangamani S, Ho B, Ding JL. The ancient origin of the complement system. EMBO J 2005; 24:382–394.
   PubMed Web of Science ®Google Scholar
• Smith LC, Clow LA, Terwilliger DP. The ancestral complement system in sea urchins. Immunol Rev 2001; 180:16–34.
   PubMedGoogle Scholar
• Ahearn JM, Fearon DT. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv Immunol 1989; 46:183–219.
   PubMed Web of Science ®Google Scholar
• Rosen H, Law SKA. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr Top Microbiol Immunol 1990; 153:99–122.
   PubMed Web of Science ®Google Scholar
• Law SK, Minich TM, Levine RP. Binding reaction between the third human complement protein and small molecules. Biochemistry 1981; 20:7457–7463.
   PubMedGoogle Scholar
• Kozel TR, Brown RR, Pfrommer GS. Activation and binding of C3 by Candida albicans. Infect Immun 1987; 55:1890–1894.
   PubMedGoogle Scholar
• Kozel TR, Wilson MA, Farrel TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 1989; 57:2412–2417.
   Google Scholar
• Young BJ, Kozel TR. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect Immun 1993; 61:2966–2972.
   PubMedGoogle Scholar
• Zhang MX, Klein B. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect Immun 1997; 65:1849–1855.
   PubMedGoogle Scholar
• Granja LFZ, Pinto L, Alviano DS, . Activation of human complement system by Mucor polymorphosporus mycelia. The Open Mycol J 2008; 2:94–99.
   Google Scholar
• Gadjeva MG, Rouseva MM, Zlatarova AS, . Interaction of Human C1q with IgG and IgM: Revisited. Biochemistry 2008; 47:13093–13102.
   PubMedGoogle Scholar
• Casey R, Newcombe J, McFadden J, Bodman-Smith KB. The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun 2008; 76:1298–1304.
   PubMedGoogle Scholar
• Sobota A, Strzelecka-Kiliszek A, Gladkowska E, . Binding of IgG-opsonized particles to Fc gamma R is an active stage of phagocytosis that involves receptor clustering and phosphorylation. J Immunol 2005; 175:4450–4457.
   Google Scholar
• Mold C, Du Clos TW. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors. J Immunol 2006; 176:7598–7604.
   PubMedGoogle Scholar
• Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171:715–727.
   PubMed Web of Science ®Google Scholar
• Gutzmer R, Köther B, Zwirner J, . Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 2006; 126:2422–2429.
   PubMedGoogle Scholar
• Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin – a soluble pattern recognition molecule. Mol Immunol 2004; 41:113–121.
   PubMed Web of Science ®Google Scholar
• Bartnicki-Garcia S. Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 1968; 22:87–108.
   PubMed Web of Science ®Google Scholar